C-erbB-3 in Human Breast Carcinoma: Expression and Prognosis
Author Information
Author(s): A Travis, SE Pinder, JFR Robertson, JA Bell, P Wencyk, WJ Gullick, RI Nicholson, DN Poller, RW Blamey, CW Elston, IO Ellis
Primary Institution: City Hospital, Nottingham
Hypothesis
The study aimed to observe the expression of the c-erbB-3 protein and investigate any relationship between expression and established prognostic indicators and prognosis.
Conclusion
The study found variable expression of c-erbB-3 protein in human breast carcinoma and an association with some recognized prognostic factors in patients with primary operable breast carcinoma.
Supporting Evidence
- 15% of primary operable cases showed strong positive staining for c-erbB-3.
- 35% of advanced cases showed strong positive staining for c-erbB-3.
- No significant associations were found between c-erbB-3 expression and overall survival in either patient group.
- An association was seen between c-erbB-3 immunoreactivity and tumor size.
- Moderate and strong c-erbB-3 staining was linked to a higher likelihood of local recurrence.
Takeaway
This study looked at a protein called c-erbB-3 in breast cancer and found that while it varies a lot in tumors, it doesn't seem to help predict how well patients will do.
Methodology
The study used immunohistochemical techniques to assess c-erbB-3 protein expression in tumor samples from patients with primary operable and advanced breast cancer.
Limitations
The study suggests that c-erbB-3 protein expression is unlikely to be a powerful enough prognostic factor to be of value in clinical practice.
Participant Demographics
Patients included 346 with primary operable breast cancer and 145 with advanced breast cancer.
Statistical Information
P-Value
P=0.05
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website